In phase 3 clinical trials, tirzepatide improved liver fibrosis in individuals with metabolic dysfunction-associated steatohepatitis (MASH) 4 , and outperformed semaglutide in the management of obesity 1 and type 2 diabetes 2
All medicines should be kept out of the reach of children
Disclosure of safety information in foreign countries The GLP-1 receptor agonist used for this treatment has been approved for the indication of obesity by the FDA in the United States, the MFDS in South Korea, and the EMA in EU27 countries
Inspired by high-quality Japanese skincare innovation, this powerful blend combines Glutathione, NAD, EGF, and essential skin nutrients to help restore a clearer, smoother, and more radiant complexion
"'Meet the Netflix for Fitness: FitFusion"
WW offers food tracking and lifestyle coaching to help people lose weight